BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 33914601)

  • 1. Inflammatory and Biomechanical Drivers of Endothelial-Interstitial Interactions in Calcific Aortic Valve Disease.
    Driscoll K; Cruz AD; Butcher JT
    Circ Res; 2021 Apr; 128(9):1344-1370. PubMed ID: 33914601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate and adaptive immunity: the understudied driving force of heart valve disease.
    Bartoli-Leonard F; Zimmer J; Aikawa E
    Cardiovasc Res; 2021 Nov; 117(13):2506-2524. PubMed ID: 34432007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis.
    Blaser MC; Kraler S; Lüscher TF; Aikawa E
    Circ Res; 2021 Apr; 128(9):1371-1397. PubMed ID: 33914608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipid theory in the pathogenesis of calcific aortic stenosis.
    Parisi V; Leosco D; Ferro G; Bevilacqua A; Pagano G; de Lucia C; Perrone Filardi P; Caruso A; Rengo G; Ferrara N
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):519-25. PubMed ID: 25816732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcific aortic stenosis: same old story?
    Cowell SJ; Newby DE; Boon NA; Elder AT
    Age Ageing; 2004 Nov; 33(6):538-44. PubMed ID: 15308457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive immune cells in calcific aortic valve disease.
    Raddatz MA; Madhur MS; Merryman WD
    Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H141-H155. PubMed ID: 31050556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for Prevention and Treatment of Aortic Stenosis: How Close Are We?
    Afshar M; Yazdan-Ashoori S; Engert JC; Thanassoulis G
    Can J Cardiol; 2021 Jul; 37(7):1016-1026. PubMed ID: 33677100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic Valve Stenosis and Mitochondrial Dysfunctions: Clinical and Molecular Perspectives.
    Pedriali G; Morciano G; Patergnani S; Cimaglia P; Morelli C; Mikus E; Ferrari R; Gasbarro V; Giorgi C; Wieckowski MR; Pinton P
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.
    Freeman RV; Otto CM
    Circulation; 2005 Jun; 111(24):3316-26. PubMed ID: 15967862
    [No Abstract]   [Full Text] [Related]  

  • 10. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation.
    Passmore M; Nataatmadja M; Fung YL; Pearse B; Gabriel S; Tesar P; Fraser JF
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):e20-9. PubMed ID: 26273067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferons Are Pro-Inflammatory Cytokines in Sheared-Stressed Human Aortic Valve Endothelial Cells.
    Parra-Izquierdo I; Sánchez-Bayuela T; López J; Gómez C; Pérez-Riesgo E; San Román JA; Sánchez Crespo M; Yacoub M; Chester AH; García-Rodríguez C
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a three-cuspid aortic valve.
    Peltier M; Trojette F; Sarano ME; Grigioni F; Slama MA; Tribouilloy CM
    Am J Cardiol; 2003 Jan; 91(1):97-9. PubMed ID: 12505584
    [No Abstract]   [Full Text] [Related]  

  • 13. Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells.
    Choi B; Lee S; Kim SM; Lee EJ; Lee SR; Kim DH; Jang JY; Kang SW; Lee KU; Chang EJ; Song JK
    Circulation; 2017 May; 135(20):1935-1950. PubMed ID: 28179397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis.
    Meng X; Ao L; Song Y; Babu A; Yang X; Wang M; Weyant MJ; Dinarello CA; Cleveland JC; Fullerton DA
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C29-35. PubMed ID: 17942642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent native aortic valve function after transcatheter aortic valve replacement.
    Singh V; Martinez CA; O'Neill WW; Heldman AW
    Tex Heart Inst J; 2013; 40(3):364-6. PubMed ID: 23914043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis.
    Tsimikas S
    Circ Res; 2019 Feb; 124(3):405-415. PubMed ID: 30702993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation is associated with the remodeling of calcific aortic valve disease.
    Coté N; Mahmut A; Bosse Y; Couture C; Pagé S; Trahan S; Boulanger MC; Fournier D; Pibarot P; Mathieu P
    Inflammation; 2013 Jun; 36(3):573-81. PubMed ID: 23225202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mouse model of aortic valve stenosis induced by direct wire injury.
    Honda S; Miyamoto T; Watanabe T; Narumi T; Kadowaki S; Honda Y; Otaki Y; Hasegawa H; Netsu S; Funayama A; Ishino M; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyashita T; Kubota I
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):270-8. PubMed ID: 24311378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic stenosis: role of balloon aortic valvuloplasty.
    Baber U; Kini AS; Moreno PR; Sharma SK
    Cardiol Clin; 2013 Aug; 31(3):327-36. PubMed ID: 23931097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic valve stenosis and lipid-lowering therapy: the state of the art.
    Bonadei I; Vizzardi E; D'aloia A; Gelsomino S; De Cicco G; Lorusso R; Dei Cas L
    Panminerva Med; 2013 Dec; 55(4):391-5. PubMed ID: 24434347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.